| Primary |
| Product Used For Unknown Indication |
75.0% |
| Depression |
16.7% |
| Epilepsy |
8.3% |
|
| Somnolence |
33.3% |
| Therapeutic Response Unexpected |
33.3% |
| Toxicity To Various Agents |
33.3% |
|
| Secondary |
| Product Used For Unknown Indication |
24.5% |
| Depression |
24.2% |
| Pain |
7.3% |
| Drug Use For Unknown Indication |
7.0% |
| Insomnia |
7.0% |
| Headache |
5.5% |
| Anxiety |
4.3% |
| Psychotic Disorder |
3.0% |
| Migraine |
2.9% |
| Neck Pain |
2.5% |
| Takayasu's Arteritis |
2.2% |
| Mental Disorder |
1.9% |
| Delirium |
1.8% |
| Hypertension |
1.2% |
| Parkinson's Disease |
1.1% |
| Depressed Mood |
0.8% |
| Drug Dependence |
0.8% |
| Irritability |
0.8% |
| Sleep Disorder |
0.7% |
| Blood Pressure Increased |
0.5% |
|
| Toxicity To Various Agents |
9.6% |
| Overdose |
8.2% |
| Therapeutic Agent Toxicity |
6.8% |
| Death |
5.5% |
| Faeces Hard |
5.5% |
| Fall |
5.5% |
| Nausea |
5.5% |
| Pneumonia Aspiration |
5.5% |
| Sinus Bradycardia |
5.5% |
| Skin Lesion |
5.5% |
| Tremor |
5.5% |
| Constipation |
4.1% |
| Faecaloma |
4.1% |
| Gastrooesophageal Reflux Disease |
4.1% |
| Suicidal Ideation |
4.1% |
| Ventricular Hypoplasia |
4.1% |
| Brugada Syndrome |
2.7% |
| Drug Interaction |
2.7% |
| Haemorrhoids |
2.7% |
| Hallucination |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.4% |
| Drug Use For Unknown Indication |
14.2% |
| Depression |
10.2% |
| Prophylaxis |
8.1% |
| Hypertension |
5.2% |
| Parkinson's Disease |
4.5% |
| Pain |
2.7% |
| Hiv Infection |
2.6% |
| Osteoporosis |
1.9% |
| Anxiety |
1.8% |
| Epilepsy |
1.8% |
| Thrombosis Prophylaxis |
1.8% |
| Antidepressant Therapy |
1.6% |
| Insomnia |
1.6% |
| Myoclonic Epilepsy |
1.6% |
| Status Epilepticus |
1.6% |
| Psoriasis |
1.5% |
| Atrial Fibrillation |
1.3% |
| Back Pain |
1.3% |
| Dementia Alzheimer's Type |
1.3% |
|
| Somnolence |
8.9% |
| Tremor |
8.9% |
| Renal Failure Acute |
7.6% |
| Thrombocytopenia |
7.6% |
| Weight Increased |
7.6% |
| Platelet Count Decreased |
5.1% |
| Renal Failure |
5.1% |
| Sepsis |
5.1% |
| Death |
3.8% |
| Depression |
3.8% |
| Gamma-glutamyltransferase Increased |
3.8% |
| Hemiparesis |
3.8% |
| Myoclonus |
3.8% |
| Overdose |
3.8% |
| Psychotic Disorder |
3.8% |
| Rash |
3.8% |
| Rhabdomyolysis |
3.8% |
| Status Epilepticus |
3.8% |
| Vertigo |
3.8% |
| Cholestasis |
2.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
80.0% |
| Depression |
20.0% |
|
| Torsade De Pointes |
50.0% |
| Tremor |
50.0% |
|
